Collective Family Office LLC Sells 212 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Collective Family Office LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 18.1% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 958 shares of the healthcare conglomerate’s stock after selling 212 shares during the period. Collective Family Office LLC’s holdings in UnitedHealth Group were worth $560,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Bell Investment Advisors Inc increased its holdings in shares of UnitedHealth Group by 4.8% in the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after acquiring an additional 24 shares in the last quarter. Harbor Investment Advisory LLC boosted its holdings in shares of UnitedHealth Group by 3.2% in the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after buying an additional 1,129 shares during the period. Austin Private Wealth LLC raised its holdings in shares of UnitedHealth Group by 9.8% during the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after acquiring an additional 111 shares during the period. Capital Insight Partners LLC boosted its stake in UnitedHealth Group by 3.8% in the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock worth $4,475,000 after purchasing an additional 332 shares during the period. Finally, Global Assets Advisory LLC bought a new stake in shares of UnitedHealth Group in the first quarter valued at about $282,469,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $1.55 during midday trading on Friday, hitting $591.20. The stock had a trading volume of 2,463,201 shares, compared to its average volume of 3,965,528. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $544.13 billion, a P/E ratio of 36.14, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The company’s 50-day moving average price is $582.24 and its 200-day moving average price is $527.36. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.14 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent analyst reports. UBS Group boosted their target price on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a report on Thursday, July 18th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. HSBC raised their price objective on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Royal Bank of Canada increased their price objective on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Finally, StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, September 25th. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $614.17.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.